IPAMORELIN 20mg/vial 1 Vial by Bluepeps

Usage

1. Remove the Bluepeps Ipamorelin vial from cold storage (2–8 °C) and allow it to equilibrate to room temperature for 5 minutes before reconstitution.
2. Wipe the vial septum with a 70 % isopropyl alcohol swab and allow to air-dry for 30 seconds.
3. Draw the desired volume of bacteriostatic water into an insulin syringe — 2 mL for a 10 mg/mL solution or 4 mL for a 5 mg/mL solution — and inject slowly down the inner glass wall of the vial, not directly onto the lyophilised cake.
4. Gently swirl (do not shake) until the powder dissolves completely; the solution should appear clear and colourless. If particulate matter is visible, do not use.
5. Draw the calculated dose volume into a fresh 29–31 gauge insulin syringe, pinch a fold of abdominal or lateral thigh skin, insert the needle at approximately 45°, and inject slowly over 5–10 seconds. Rotate injection sites between administrations.
6. Recap the vial, return it to the refrigerator at 2–8 °C, and log the reconstitution date; discard any remaining solution after 28 days regardless of volume remaining.

Warnings

Frequently asked questions

What solvent should you use to reconstitute Ipamorelin peptide vials?

Bacteriostatic water containing 0.9 % benzyl alcohol is the recommended reconstitution solvent for Ipamorelin. Unlike plain sterile water, it inhibits microbial growth across multiple withdrawal events, extending usable vial life to approximately 28 days when refrigerated. Inject solvent slowly down the vial's inner glass wall — not directly onto the lyophilised powder — and swirl gently until fully dissolved.

How should reconstituted Ipamorelin be stored in the refrigerator?

Once reconstituted, Ipamorelin vials must be stored upright at 2–8 °C, away from direct light, and used within 28 days. Avoid placing vials in the refrigerator door, where temperature fluctuates with opening cycles. Freeze-thaw cycling degrades peptide integrity and should be avoided entirely; if the lyophilised vial has not yet been reconstituted, it may tolerate short-term room temperature but long-term cold storage is standard.

How does subcutaneous injection of a peptide differ from intramuscular injection?

Subcutaneous injection deposits the solution into the fatty tissue layer just beneath the skin, typically using a 29–31 gauge insulin needle 8–12.7 mm long. Compared to intramuscular delivery, the subcutaneous route produces more consistent absorption kinetics with less inter-subject variability and causes less injection-site discomfort. Pinch a fold of abdominal or lateral thigh tissue, insert the needle at a 45° angle, and inject slowly.

Why does the 20 mg/vial concentration make dosing with an insulin syringe easier?

The 20 mg/vial concentration is the highest in this product group, giving researchers flexible dilution options. Adding 2 mL bacteriostatic water yields 10 mg/mL; adding 4 mL yields 5 mg/mL. Both concentrations align cleanly with U-100 insulin syringe markings — for example, a 200 mcg dose drawn from a 10 mg/mL solution equals 2 units on a U-100 syringe — eliminating complex mental arithmetic during preparation.

How does Bluepeps verify that each Ipamorelin vial actually contains the declared 20 mg?

Bluepeps applies a two-stage batch-level release protocol: reversed-phase HPLC confirms both amino-acid sequence identity and active-content accuracy against the 20 mg per vial specification, while a Limulus Amebocyte Lysate (LAL) endotoxin assay quantifies residual pyrogenic load before dispatch. Only vials that clear both checkpoints receive a lot-specific certificate of analysis, making the 20 mg declaration a measured — not nominal — figure. (2) angle_used

Manufacturer

Formulation innovation at Bluepeps centres on solving a practical problem inherent to high-concentration single-ingredient peptide vials: ensuring that 20 mg of active content survives lyophilisation, cold-chain transit and repeated reconstitution events without sequence degradation. To address this, Bluepeps' development workflow anchors concentration accuracy to two independent analytical methods — reversed-phase HPLC for sequence identity and active-content verification against the declared 20 mg specification, and a Limulus Amebocyte Lysate endotoxin assay to confirm residual pyrogenic load remains within defined release thresholds. Vials are lyophilised under ISO-classified cleanroom conditions and sealed under inert atmosphere, a combination chosen specifically to protect peptide cake integrity during the cold-chain period before reconstitution. A lot-specific certificate of analysis is generated as the final output of this release sequence, giving end-users a traceable quality record tied to the exact batch in hand.